INTELLIA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 78.98K shares, a 3713.57% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 2.07K shares, a 96.83% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 181.49K shares, a 24.73% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-06-30 was 79.51K shares, a 161.80% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 87.86K shares, a 76.50% decline from fiscal 2024.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 373.81K shares, a 2.94% decline from fiscal 2023.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 385.13K shares, a 56.43% decline from fiscal 2022.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 883.95K shares, a 67.27% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 78.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 87.86K shares 10-K · filed 2026-02-26 |
| 2024-12-31 | 2.07K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 373.81K shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 181.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 437.02K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 79.51K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 496.65K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 110.73K shares 10-Q · filed 2024-05-09 | 447.51K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 65.28K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 385.13K shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 241.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 350.89K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 30.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 143.10K shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 48.35K shares 10-Q · filed 2023-05-04 | 428.48K shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 31.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 883.95K shares 10-K · filed 2023-02-23 |
| 2022-09-30 | 33.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 917.36K shares derived: sum of 4 quarters · filed 2023-02-23 |
| 2022-06-30 | 315.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 2.11M shares derived: sum of 4 quarters · filed 2023-02-23 |
| 2022-03-31 | 503.83K shares 10-Q · filed 2022-05-05 | 2.19M shares derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-12-31 | 64.45K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 2.70M shares 10-K · filed 2023-02-23 |
| 2021-09-30 | 1.23M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 3.27M shares derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | 394.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 2.11M shares derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | 1.01M shares 10-Q · filed 2021-05-06 | 1.80M shares derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | 635.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 840.82K shares 10-K · filed 2023-02-23 |
| 2020-09-30 | 67.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 314.40K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 83.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 267.74K shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | 53.58K shares 10-Q · filed 2020-05-07 | 387.18K shares derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | 109.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 364.40K shares 10-K · filed 2020-02-27 |
| 2019-09-30 | 21.31K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 415.99K shares derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | 203.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 599.33K shares derived: sum of 4 quarters · filed 2019-08-01 |
| 2019-03-31 | 30.80K shares 10-Q · filed 2019-05-02 | 464.42K shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2018-12-31 | 160.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | 1.14M shares 10-K · filed 2019-02-27 |
| 2018-09-30 | 204.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | 1.05M shares derived: sum of 4 quarters · filed 2018-10-31 |
| 2018-06-30 | 68.16K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | 898.27K shares derived: sum of 4 quarters · filed 2018-08-01 |
| 2018-03-31 | 709.32K shares 10-Q · filed 2018-05-01 | 843.94K shares derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-12-31 | 68.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | 141.76K shares 10-K · filed 2018-03-14 |
| 2017-09-30 | 52.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | |
| 2017-06-30 | 13.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | |
| 2017-03-31 | 7.14K shares 10-Q · filed 2017-05-02 | |
| 2016-12-31 | 257.00 shares 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |